Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Deciphera Pharmaceuticals, Inc. | d424769dex322.htm |
| EX-32.1 - EXHIBIT 32.1 - Deciphera Pharmaceuticals, Inc. | d424769dex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Deciphera Pharmaceuticals, Inc. | d424769dex312.htm |
| EX-31.1 - EXHIBIT 31.1 - Deciphera Pharmaceuticals, Inc. | d424769dex311.htm |
| EX-21.1 - EXHIBIT 21.1 - Deciphera Pharmaceuticals, Inc. | d424769dex211.htm |
| 10-K - FORM 10-K - Deciphera Pharmaceuticals, Inc. | d424769d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333- 220866) of Deciphera Pharmaceuticals, Inc. of our report dated March 28, 2018 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 28, 2018